Oppenheimer Asset Management Inc. Takes Position in Corteva, Inc. $CTVA

Oppenheimer Asset Management Inc. bought a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 6,872 shares of the company’s stock, valued at approximately $582,000.

Several other institutional investors also recently bought and sold shares of the stock. Bryn Mawr Trust Advisors LLC purchased a new stake in Corteva in the 2nd quarter worth $1,938,000. Tema ETFs LLC increased its holdings in shares of Corteva by 10.4% in the second quarter. Tema ETFs LLC now owns 10,774 shares of the company’s stock worth $912,000 after purchasing an additional 1,015 shares during the last quarter. City Holding Co. increased its holdings in shares of Corteva by 2.6% in the second quarter. City Holding Co. now owns 25,086 shares of the company’s stock worth $2,124,000 after purchasing an additional 635 shares during the last quarter. Sax Wealth Advisors LLC purchased a new stake in shares of Corteva in the second quarter worth about $237,000. Finally, Avity Investment Management Inc. lifted its position in shares of Corteva by 14.4% in the second quarter. Avity Investment Management Inc. now owns 5,172 shares of the company’s stock worth $438,000 after buying an additional 650 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Down 1.2%

Shares of NYSE:CTVA opened at $75.73 on Tuesday. The firm has a market capitalization of $50.53 billion, a PE ratio of 50.15, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. The business has a 50 day simple moving average of $81.78 and a two-hundred day simple moving average of $80.09. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the business posted $2.20 earnings per share. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. raised their price target on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a report on Monday, August 3rd. Royal Bank Of Canada upped their price objective on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Finally, Barclays upped their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $91.70.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.